Treatment of transplant rejection in the presence of cytomegalovirus viremia
O'Hair, D.P.; Johnson, C.P.; Roza, A.M.; Adams, M.B.
Transplantation Proceedings 22(4): 1815-1817
1990
ISSN/ISBN: 0041-1345 PMID: 2167537 Document Number: 358049
Document emailed within 1 workday
Related Documents
Kishore, J.; Mukhopadhyay, C.; Savitri; Ayyagari, A.; Sharma, R.K. 2004: Sero-molecular evaluation of human cytomegalovirus disease in renal transplant rejection Nepal Medical College Journal: Nmcj 6(2): 83-87Metselaar, H.J.; Rothbarth, P.H.; Brouwer, R.M.; Wenting, G.J.; Jeekel, J.; Weimar, W. 1989: Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejection Transplantation 48(2): 264-266
Metselaar, H.J.; Velzing, J.; Rothbarth, P.H.; Simoons, M.L.; Bos, E.; Weimar, W. 1987: A pharmacokinetic study of anti-cytomegalovirus hyperimmunoglobulins in cytomegalovirus seronegative cardiac transplant recipients Transplantation Proceedings 19(5): 4063-4065
Reed, E.C. 1991: Treatment of cytomegalovirus pneumonia in transplant patients Transplantation Proceedings 23(2 Suppl 1: 8-12
Sawinski, D.; Trofe-Clark, J. 2015: BKV Viremia and Development of de Novo DSA in Renal Transplant Recipients Clinical Transplants 31: 249-256
Terlizzi, M.E.; Costa, C.; Astegiano, S.; Sidoti, F.; Vendrame, R.; Segoloni, G.P.; Bergallo, M.; Cavallo, R. 2008: Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies Minerva Medica 99(3): 231-239
Terlizzi, M.E.; Costa, C.; Astegiano, S.; Sidoti, F.; Vendrame, R.; Segoloni, G.P.; Bergallo, M.; Cavallo, R. 2008: Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies Minerva Medica 99(3): 231-239
Fielding, K.; Koba, A.; Grant, A.D.; Charalambous, S.; Day, J.; Spak, C.; Wald, A.; Huang, M.-L.; Corey, L.; Churchyard, G.J. 2011: Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa Plos one 6(10): E25571
Lautenschlager, I.; Ahonen, J.; Eklund, B.; Höckerstedt, K.; Isoniemi, H.; Salmela, K.; Häyry, P. 1990: Detection of cytomegalovirus-specific early antigens from blood leukocytes and bronchoalveolar lavage cells in the diagnosis of active cytomegalovirus infection in transplant patients Transplantation Proceedings 22(1): 233
Pleskova, A.V.; Khvatova, A.V. 2002: Transplant rejection: general questions of pathogenesis, diagnosis and treatment Vestnik Oftalmologii 118(6): 46-51
Reitz, B.A.; Gaudiani, V.A.; Hunt, S.A.; Wallwork, J.; Billingham, M.E.; Oyer, P.E.; Baumgartner, W.A.; Jamieson, S.W.; Stinson, E.B.; Shumway, N.E. 1983: Diagnosis and treatment of allograft rejection in heart-lung transplant recipients Journal of Thoracic and Cardiovascular Surgery 85(3): 354-361
Pozo, F.; Tenorio, A.; de la Mata, M.; de Ory, F.; Torre-Cisneros, J. 2000: Persistent human herpesvirus 8 viremia before Kaposi's sarcoma development in a liver transplant recipient Transplantation 70(2): 395-397
Hengster, P.; Pescovitz, M.D.; Hyatt, D.; Margreiter, R. 1999: Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group Transplantation 68(2): 310-313
Matl, I.; Gintelová, J.; Jirka, J.; Rossmann, P. 1993: Graft rejection after changing from cyclosporin A therapy to conventional treatment in kidney transplant patients Casopis Lekaru Ceskych 132(10): 301-304
Peraldi, M.N.; Rondeau, E.; Bellaj, A.; Kanfer, A.; Sraer, J.D. 1988: Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients Clinical Nephrology 29(1): 52
Tellis, V.A.; Matas, A.J.; Quinn, T.A.; Glicklich, D.; Weiss, R.J.; Soberman, R.J.; Veith, F.J. 1987: Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients Transplantation Proceedings 19(1 Part 3): 1892
Noël, C.; Hazzan, M.; Coppin, M.C.; Pruvot, F.R.; Bridoux, F.; Lelièvre, G. 1995: Renal transplant artery thrombosis following treatment of allograft rejection with monoclonal anti-CD3 antibodies (OKT3) Transplantation Proceedings 27(4): 2438-2439
Siennicka, J.; Durlik, M.; Litwińska, B.; Chmura, A.; Lewandowska, D.; Lao, M.; Paczek, L.; Kańtoch, M. 1999: Identification of cytomegalovirus (CMV) infection by different laboratory methods in renal transplant recipients undergoing triple-drug immunosupressive treatment Acta Microbiologica Polonica 48(1): 61-71
Bonaros, N.E.; Kocher, A.; Dunkler, D.; Grimm, M.; Zuckermann, A.; Ankersmit, J.; Ehrlich, M.; Wolner, E.; Laufer, Günther. 2004: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients Transplantation 77(6): 890-897
Stals, F.S.; Zeytinoglu, A.; Havennith, M.; de Clercq, E.; Bruggeman, C.A. 1993: Comparative effect of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine treatment on cytomegalovirus-induced interstitial pneumonitis in allogeneic bone marrow transplant recipient rats Transplantation Proceedings 25(1 Part 2): 1248-1249